GO ID |
Ontology |
GO Term |
Term Definition |
Proteins |
GO:1902751
|
BP
|
positive regulation of cell cycle G2/M phase transition
|
Any process that activates or increases the frequency, rate or extent of cell cycle G2/M phase transition.
|
NPM1
|
GO:1902766
|
BP
|
skeletal muscle satellite cell migration
|
The orderly movement of a skeletal muscle satellite cell from one site to another. Migration of these cells is a key step in the process of growth and repair of skeletal muscle cells.
|
RHOA
|
GO:1902771
|
BP
|
positive regulation of choline O-acetyltransferase activity
|
Any process that activates or increases the frequency, rate or extent of choline O-acetyltransferase activity.
|
SORL1
|
GO:1902774
|
BP
|
late endosome to lysosome transport
|
The directed movement of substances from late endosome to lysosome.
|
SNAPIN
|
GO:1902775
|
BP
|
mitochondrial large ribosomal subunit assembly
|
The aggregation, arrangement and bonding together of a set of components to form a mitochondrial large ribosomal subunit.
|
DHX30,
DDX28
|
GO:1902803
|
BP
|
regulation of synaptic vesicle transport
|
Any process that modulates the frequency, rate or extent of synaptic vesicle transport.
|
PARK2,
PINK1
|
GO:1902806
|
BP
|
regulation of cell cycle G1/S phase transition
|
Any process that modulates the frequency, rate or extent of cell cycle G1/S phase transition.
|
ATP2B4
|
GO:1902808
|
BP
|
positive regulation of cell cycle G1/S phase transition
|
Any process that activates or increases the frequency, rate or extent of cell cycle G1/S phase transition.
|
PHB2,
PAGR1,
FAM83D
|
GO:1902809
|
BP
|
regulation of skeletal muscle fiber differentiation
|
Any process that modulates the frequency, rate or extent of skeletal muscle fiber differentiation.
|
NLN
|
GO:1902823
|
BP
|
negative regulation of late endosome to lysosome transport
|
Any process that stops, prevents or reduces the frequency, rate or extent of late endosome to lysosome transport.
|
VPS35
|
GO:1902824
|
BP
|
positive regulation of late endosome to lysosome transport
|
Any process that activates or increases the frequency, rate or extent of late endosome to lysosome transport.
|
SNAPIN,
ARF1
|
GO:1902828
|
BP
|
positive regulation of L-arginine import into cell
|
Any process that activates or increases the frequency, rate or extent of L-arginine import into cell.
|
AGT
|
GO:1902847
|
BP
|
regulation of neuronal signal transduction
|
Any process that modulates the frequency, rate or extent of neuronal signal transduction.
|
CLU
|
GO:1902850
|
BP
|
microtubule cytoskeleton organization involved in mitosis
|
Any microtubule cytoskeleton organization that is involved in mitosis.
|
TACC3
|
GO:1902856
|
BP
|
negative regulation of nonmotile primary cilium assembly
|
Any process that stops, prevents or reduces the frequency, rate or extent of nonmotile primary cilium assembly.
|
MAK
|
GO:1902857
|
BP
|
positive regulation of nonmotile primary cilium assembly
|
Any process that activates or increases the frequency, rate or extent of nonmotile primary cilium assembly.
|
SEPT7,
CEP135,
CENPJ,
WRAP73
|
GO:1902861
|
BP
|
copper ion import into cell
|
The directed movement of copper ions from outside of a cell into the cytoplasmic compartment. This may occur via transport across the plasma membrane or via endocytosis.
|
SLC31A1
|
GO:1902884
|
BP
|
positive regulation of response to oxidative stress
|
Any process that activates or increases the frequency, rate or extent of response to oxidative stress.
|
SEPN1
|
GO:1902891
|
BP
|
negative regulation of root hair elongation
|
Any process that stops, prevents or reduces the frequency, rate or extent of root hair elongation.
|
GAL
|
GO:1902894
|
BP
|
negative regulation of pri-miRNA transcription from RNA polymerase II promoter
|
Any process that stops, prevents or reduces the frequency, rate or extent of pri-miRNA transcription from RNA polymerase II promoter.
|
NFIB,
PDGFB,
SOX9,
PPARD,
PPARA,
NFATC4
|
GO:1902895
|
BP
|
positive regulation of pri-miRNA transcription from RNA polymerase II promoter
|
Any process that activates or increases the frequency, rate or extent of pri-miRNA transcription from RNA polymerase II promoter.
|
SMAD6,
FOS,
PDGFB,
TGFB1,
JUN,
NGFR,
BMP2,
BMP4,
BMPR1A,
STAT3,
SMARCA4,
SMAD3,
RELA,
SMAD1,
HIF1A,
GNL3
|
GO:1902896
|
BP
|
terminal web assembly
|
The aggregation, arrangement and bonding together of a set of components to form a terminal web.
|
EZR,
PLS1
|
GO:1902897
|
BP
|
regulation of postsynaptic density protein 95 clustering
|
Any process that modulates the frequency, rate or extent of postsynaptic density protein 95 clustering.
|
CDH2,
CRIPT
|
GO:1902902
|
BP
|
negative regulation of autophagosome assembly
|
Any process that stops, prevents or reduces the frequency, rate or extent of autophagosome assembly.
|
MTM1,
FEZ1,
PINK1,
CHMP4B
|
GO:1902905
|
BP
|
positive regulation of fibril organization
|
Any process that activates or increases the frequency, rate or extent of fibril organization.
|
GPX1
|
GO:1902916
|
BP
|
positive regulation of protein polyubiquitination
|
Any process that activates or increases the frequency, rate or extent of protein polyubiquitination.
|
SKP2
|
GO:1902943
|
BP
|
positive regulation of voltage-gated chloride channel activity
|
Any process that activates or increases the frequency, rate or extent of voltage-gated chloride channel activity.
|
CFTR,
PTAFR
|
GO:1902946
|
BP
|
protein localization to early endosome
|
A process in which a protein is transported to, or maintained in, a location within an early endosome.
|
NRP1
|
GO:1902947
|
BP
|
regulation of tau-protein kinase activity
|
Any process that modulates the frequency, rate or extent of tau-protein kinase activity.
|
HGF
|
GO:1902948
|
BP
|
negative regulation of tau-protein kinase activity
|
Any process that stops, prevents or reduces the frequency, rate or extent of tau-protein kinase activity.
|
SORL1
|
GO:1902949
|
BP
|
positive regulation of tau-protein kinase activity
|
Any process that activates or increases the frequency, rate or extent of tau-protein kinase activity.
|
CLU
|
GO:1902952
|
BP
|
positive regulation of dendritic spine maintenance
|
Any process that activates or increases the frequency, rate or extent of dendritic spine maintenance.
|
APOE
|
GO:1902953
|
BP
|
positive regulation of ER to Golgi vesicle-mediated transport
|
Any process that activates or increases the frequency, rate or extent of ER to Golgi vesicle-mediated transport.
|
ARF1,
SORL1
|
GO:1902955
|
BP
|
positive regulation of early endosome to recycling endosome transport
|
Any process that activates or increases the frequency, rate or extent of early endosome to recycling endosome transport.
|
SORL1
|
GO:1902957
|
BP
|
negative regulation of mitochondrial electron transport, NADH to ubiquinone
|
Any process that stops, prevents or reduces the frequency, rate or extent of mitochondrial electron transport, NADH to ubiquinone.
|
SNCA,
DNAJC15
|
GO:1902958
|
BP
|
positive regulation of mitochondrial electron transport, NADH to ubiquinone
|
Any process that activates or increases the frequency, rate or extent of mitochondrial electron transport, NADH to ubiquinone.
|
PINK1
|
GO:1902959
|
BP
|
regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process
|
Any process that modulates the frequency, rate or extent of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process.
|
PICALM
|
GO:1902960
|
BP
|
negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process
|
Any process that stops, prevents or reduces the frequency, rate or extent of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process.
|
SORL1
|
GO:1902961
|
BP
|
positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process
|
Any process that activates or increases the frequency, rate or extent of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process.
|
PICALM
|
GO:1902963
|
BP
|
negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process
|
Any process that stops, prevents or reduces the frequency, rate or extent of metalloendopeptidase activity involved in amyloid precursor protein catabolic process.
|
PICALM,
SORL1
|
GO:1902966
|
BP
|
positive regulation of protein localization to early endosome
|
Any process that activates or increases the frequency, rate or extent of protein localization to early endosome.
|
EZR,
RDX,
SORL1
|
GO:1902975
|
BP
|
mitotic DNA replication initiation
|
Any DNA replication initiation involved in mitotic cell cycle DNA replication.
|
GINS2
|
GO:1902979
|
BP
|
mitotic DNA replication termination
|
Any DNA replication termination involved in mitotic cell cycle DNA replication.
|
RTFDC1
|
GO:1902983
|
BP
|
DNA strand elongation involved in mitotic DNA replication
|
Any DNA strand elongation involved in mitotic cell cycle DNA replication.
|
GINS1
|
GO:1902990
|
BP
|
mitotic telomere maintenance via semi-conservative replication
|
Any telomere maintenance via semi-conservative replication that is involved in mitotic cell cycle.
|
PCNA,
DNA2
|
GO:1902995
|
BP
|
positive regulation of phospholipid efflux
|
Any process that activates or increases the frequency, rate or extent of phospholipid efflux.
|
APOE
|
GO:1902997
|
BP
|
negative regulation of neurofibrillary tangle assembly
|
Any process that stops, prevents or reduces the frequency, rate or extent of neurofibrillary tangle assembly.
|
SORL1
|
GO:1902998
|
BP
|
positive regulation of neurofibrillary tangle assembly
|
Any process that activates or increases the frequency, rate or extent of neurofibrillary tangle assembly.
|
CLU
|
GO:1903002
|
BP
|
positive regulation of lipid transport across blood brain barrier
|
Any process that activates or increases the frequency, rate or extent of lipid transport across blood brain barrier.
|
APOE
|
GO:1903003
|
BP
|
positive regulation of protein deubiquitination
|
Any process that activates or increases the frequency, rate or extent of protein deubiquitination.
|
TANK
|
GO:1903006
|
BP
|
positive regulation of protein K63-linked deubiquitination
|
Any process that activates or increases the frequency, rate or extent of protein K63-linked deubiquitination.
|
VCP
|
GO:1903007
|
BP
|
positive regulation of Lys63-specific deubiquitinase activity
|
Any process that activates or increases the frequency, rate or extent of Lys63-specific deubiquitinase activity.
|
VCP
|
GO:1903010
|
BP
|
regulation of bone development
|
Any process that modulates the frequency, rate or extent of bone development.
|
GLI3
|
GO:1903011
|
BP
|
negative regulation of bone development
|
Any process that stops, prevents or reduces the frequency, rate or extent of bone development.
|
RGN
|
GO:1903016
|
BP
|
negative regulation of exo-alpha-sialidase activity
|
Any process that stops, prevents or reduces the frequency, rate or extent of exo-alpha-sialidase activity.
|
APCS,
PTX3
|
GO:1903019
|
BP
|
negative regulation of glycoprotein metabolic process
|
Any process that stops, prevents or reduces the frequency, rate or extent of glycoprotein metabolic process.
|
APCS,
PTX3
|
GO:1903020
|
BP
|
positive regulation of glycoprotein metabolic process
|
Any process that activates or increases the frequency, rate or extent of glycoprotein metabolic process.
|
RAB1A,
RAB1B
|
GO:1903025
|
BP
|
regulation of RNA polymerase II regulatory region sequence-specific DNA binding
|
Any process that modulates the frequency, rate or extent of RNA polymerase II regulatory region sequence-specific DNA binding.
|
LIF
|
GO:1903026
|
BP
|
negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding
|
Any process that stops, prevents or reduces the frequency, rate or extent of RNA polymerase II regulatory region sequence-specific DNA binding.
|
DDIT3,
ID1
|
GO:1903033
|
BP
|
positive regulation of microtubule plus-end binding
|
Any process that activates or increases the frequency, rate or extent of microtubule plus-end binding.
|
MAPRE1,
MAPRE3
|
GO:1903034
|
BP
|
regulation of response to wounding
|
Any process that modulates the frequency, rate or extent of response to wounding.
|
IL10
|
GO:1903038
|
BP
|
negative regulation of leukocyte cell-cell adhesion
|
Any process that stops, prevents or reduces the frequency, rate or extent of leukocyte cell-cell adhesion.
|
ASS1,
PPARA
|
GO:1903044
|
BP
|
protein localization to membrane raft
|
A process in which a protein is transported to, or maintained in, a location within a membrane raft.
|
FLOT1,
RFTN1
|
GO:1903045
|
BP
|
neural crest cell migration involved in sympathetic nervous system development
|
Any neural crest cell migration that is involved in sympathetic nervous system development.
|
SEMA3A
|
GO:1903047
|
BP
|
mitotic cell cycle process
|
A process that is part of the mitotic cell cycle.
|
KIF14
|
GO:1903052
|
BP
|
positive regulation of proteolysis involved in cellular protein catabolic process
|
Any process that activates or increases the frequency, rate or extent of proteolysis involved in cellular protein catabolic process.
|
CTSC,
RGN
|
GO:1903053
|
BP
|
regulation of extracellular matrix organization
|
Any process that modulates the frequency, rate or extent of extracellular matrix organization.
|
TCF15
|
GO:1903056
|
BP
|
regulation of melanosome organization
|
Any process that modulates the frequency, rate or extent of melanosome organization.
|
ZEB2
|
GO:1903061
|
BP
|
positive regulation of protein lipidation
|
Any process that activates or increases the frequency, rate or extent of protein lipidation.
|
RAB3GAP1,
SVIP,
RAB3GAP2
|
GO:1903070
|
BP
|
negative regulation of ER-associated ubiquitin-dependent protein catabolic process
|
Any process that stops, prevents or reduces the frequency, rate or extent of ER-associated ubiquitin-dependent protein catabolic process.
|
SVIP
|
GO:1903071
|
BP
|
positive regulation of ER-associated ubiquitin-dependent protein catabolic process
|
Any process that activates or increases the frequency, rate or extent of ER-associated ubiquitin-dependent protein catabolic process.
|
SGTA,
BCAP31,
CAV1
|
GO:1903076
|
BP
|
regulation of protein localization to plasma membrane
|
Any process that modulates the frequency, rate or extent of protein localization to plasma membrane.
|
STX7,
GBP1,
SPTBN1,
VTI1B
|
GO:1903077
|
BP
|
negative regulation of protein localization to plasma membrane
|
Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to plasma membrane.
|
TGFB1,
GBP1,
NUMB,
DAB2,
AP2M1
|
GO:1903078
|
BP
|
positive regulation of protein localization to plasma membrane
|
Any process that activates or increases the frequency, rate or extent of protein localization to plasma membrane.
|
SPTBN1,
STX4,
STX3
|
GO:1903126
|
BP
|
negative regulation of centriole-centriole cohesion
|
Any process that stops, prevents or reduces the frequency, rate or extent of centriole-centriole cohesion.
|
NEK2
|
GO:1903140
|
BP
|
regulation of establishment of endothelial barrier
|
Any process that modulates the frequency, rate or extent of establishment of endothelial barrier.
|
ROCK2,
TNF,
IL1B
|
GO:1903141
|
BP
|
negative regulation of establishment of endothelial barrier
|
Any process that stops, prevents or reduces the frequency, rate or extent of establishment of endothelial barrier.
|
S1PR3
|
GO:1903142
|
BP
|
positive regulation of establishment of endothelial barrier
|
Any process that activates or increases the frequency, rate or extent of establishment of endothelial barrier.
|
CDH5
|
GO:1903146
|
BP
|
regulation of mitophagy
|
Any process that modulates the frequency, rate or extent of mitochondrion degradation (mitophagy).
|
HAX1,
BNIP3L,
ACTL6A,
SREBF1,
CTSK,
RPL28,
SREBF2,
ZBTB17,
CTTN,
PINK1,
MAP1LC3B,
ATP13A2,
USP36,
HDAC6,
RUVBL1
|
GO:1903147
|
BP
|
negative regulation of mitophagy
|
Any process that stops, prevents or reduces the frequency, rate or extent of mitochondrion degradation (mitophagy).
|
TSPO,
PINK1
|
GO:1903169
|
BP
|
regulation of calcium ion transmembrane transport
|
Any process that modulates the frequency, rate or extent of calcium ion transmembrane transport.
|
TSPAN13,
PIK3CG
|
GO:1903170
|
BP
|
negative regulation of calcium ion transmembrane transport
|
Any process that stops, prevents or reduces the frequency, rate or extent of calcium ion transmembrane transport.
|
ATP1A2
|
GO:1903202
|
BP
|
negative regulation of oxidative stress-induced cell death
|
Any process that stops, prevents or reduces the frequency, rate or extent of oxidative stress-induced cell death.
|
PARK2,
PINK1
|
GO:1903204
|
BP
|
negative regulation of oxidative stress-induced neuron death
|
Any process that stops, prevents or reduces the frequency, rate or extent of oxidative stress-induced neuron death.
|
ATF4,
PINK1
|
GO:1903206
|
BP
|
negative regulation of hydrogen peroxide-induced cell death
|
Any process that stops, prevents or reduces the frequency, rate or extent of hydrogen peroxide-induced cell death.
|
GPR37,
PSAP,
TXN,
NUP93
|
GO:1903208
|
BP
|
negative regulation of hydrogen peroxide-induced neuron death
|
Any process that stops, prevents or reduces the frequency, rate or extent of hydrogen peroxide-induced neuron death.
|
RACK1,
NR4A3
|
GO:1903214
|
BP
|
regulation of protein targeting to mitochondrion
|
Any process that modulates the frequency, rate or extent of protein targeting to mitochondrion.
|
HAX1,
BNIP3L,
PARK2,
SREBF1,
PINK1
|
GO:1903225
|
BP
|
negative regulation of endodermal cell differentiation
|
Any process that stops, prevents or reduces the frequency, rate or extent of endodermal cell differentiation.
|
COL5A2,
COL5A1
|
GO:1903232
|
BP
|
melanosome assembly
|
The aggregation, arrangement and bonding together of a set of components to form a melanosome, a tissue-specific, membrane-bounded cytoplasmic organelle within which melanin pigments are synthesized and stored.
|
TRAPPC6A,
RAB32,
HPS1,
HPS4
|
GO:1903233
|
BP
|
regulation of calcium ion-dependent exocytosis of neurotransmitter
|
Any process that modulates the frequency, rate or extent of calcium ion-dependent exocytosis of neurotransmitter.
|
ATP2A2,
RAB3GAP1
|
GO:1903237
|
BP
|
negative regulation of leukocyte tethering or rolling
|
Any process that stops, prevents or reduces the frequency, rate or extent of leukocyte tethering or rolling.
|
CXCL12
|
GO:1903238
|
BP
|
positive regulation of leukocyte tethering or rolling
|
Any process that activates or increases the frequency, rate or extent of leukocyte tethering or rolling.
|
PTAFR
|
GO:1903242
|
BP
|
regulation of cardiac muscle hypertrophy in response to stress
|
Any process that modulates the frequency, rate or extent of cardiac muscle hypertrophy in response to stress.
|
BMP10
|
GO:1903243
|
BP
|
negative regulation of cardiac muscle hypertrophy in response to stress
|
Any process that stops, prevents or reduces the frequency, rate or extent of cardiac muscle hypertrophy in response to stress.
|
ATP2B4,
ERRFI1
|
GO:1903244
|
BP
|
positive regulation of cardiac muscle hypertrophy in response to stress
|
Any process that activates or increases the frequency, rate or extent of cardiac muscle hypertrophy in response to stress.
|
PPP3CA,
TRPC3
|
GO:1903249
|
BP
|
negative regulation of citrulline biosynthetic process
|
Any process that stops, prevents or reduces the frequency, rate or extent of citrulline biosynthetic process.
|
ATP2B4
|
GO:1903262
|
BP
|
negative regulation of serine phosphorylation of STAT3 protein
|
Any process that stops, prevents or reduces the frequency, rate or extent of serine phosphorylation of STAT3 protein.
|
PWP1
|
GO:1903265
|
BP
|
positive regulation of tumor necrosis factor-mediated signaling pathway
|
Any process that activates or increases the frequency, rate or extent of tumor necrosis factor-mediated signaling pathway.
|
PARK2,
HSPA1A,
HSPA1B
|
GO:1903278
|
BP
|
positive regulation of sodium ion export from cell
|
Any process that activates or increases the frequency, rate or extent of sodium ion export from cell.
|
FXYD1,
ATP1B1,
ATP1B3
|
GO:1903280
|
BP
|
negative regulation of calcium:sodium antiporter activity
|
Any process that stops, prevents or reduces the frequency, rate or extent of calcium:sodium antiporter activity.
|
ATP1A2
|